Werfen Receives CE Mark for Aptiva Antiphospholipid Syndrome Reagents
Werfen received CE mark for its Aptiva Antiphospholipid Syndrome IgG and IgM reagents under the EU’s IVDR.
Read MorePosted by Andy Lundin | Feb 23, 2024 | Immunoassay Reagents & test Kits |
Werfen received CE mark for its Aptiva Antiphospholipid Syndrome IgG and IgM reagents under the EU’s IVDR.
Read MorePosted by Andy Lundin | Feb 16, 2024 | Cancer |
By analyzing fragments of cfDNA in a simple blood draw, the Galleri test can screen for many deadly cancers.
Read MorePosted by Andy Lundin | Feb 14, 2024 | Digital Pathology, Melanoma, Molecular Diagnostics |
A new technology in molecular imaging and pathology is paving the way for a more objective approach to melanoma diagnosis.
Read MorePosted by Andy Lundin | Feb 12, 2024 | Diagnostic Technologies |
The PFAS test from Quest Diagnostics is available as a consumer-initiated test with physician consult to report a sum of PFAS chemicals.
Read MorePosted by Andy Lundin | Feb 9, 2024 | Diagnostic Technologies, Womens Health |
Fort Worth Diagnostics utilizes digital PCR to establish the assays and ensure reproducibility while manufacturing high-quality materials.
Read More